Pharma May Get Reprieve From Rule Penalizing Drugmakers For Overcharging Hospitals
The Trump administration suggested that it may further delay the controversial rule and that it is now seeking public input about a postponement.
The independent source for health policy research, polling, and news.
31,821 - 31,840 of 112,370 Results
The Trump administration suggested that it may further delay the controversial rule and that it is now seeking public input about a postponement.
“We’re entering a new frontier in medical innovation with the ability to reprogram a patient’s own cells to attack a deadly cancer,” Food and Drug Administration Commissioner Scott Gottlieb said. The price tag on the treatment is $475,000.
The decision puts junior Sen. Kamala Harris (D-Calif.) at odds with Sen. Dianne Feinstein (D-Calif.), who has cited concerns about the costs of such a plan.
The leaders wrote to Congress saying that getting rid of the insurer subsidies would cause premiums to spike. Meanwhile, Ohio Gov. John Kasich and Colorado Gov. John Hickenlooper are working on their own proposal to tweak the health law.
The official, who spoke to The New York Times, says President Donald Trump wants to stabilize the marketplace, but wouldn't commit to saying the administration will pay for insurer subsidies or promote enrollment for the next year.
Today's early morning highlights from the major news organizations.
A selection of opinions on public health issues from around the country.
Read recent commentaries about drug-cost issues.
News outlets report on stories related to pharmaceutical pricing.
Media outlets report on news from Texas, Ohio, California, New Jersey, New Hampshire, Minnesota and Florida.
UnitedHealth’s health services arm, Optum, has grown rapidly over the years with an aggressive spate of acquisitions.
In the meantime, transgender troops will be allowed to continue to serve.
Funding runs out at the end of September for CHIP, which covers 8 million children around the country. But some lawmakers hope to attach more controversial measures to the bill. Also, a federal Medicaid program to help fight substance abuse is getting a slow start while California's efforts are leading the way. And in Georgia, a new leader is named for the state Medicaid program.
Virginia Madueño says that after she attended a local health care town hall she realized “not only did I have a story to share but I had a cause, if you will. I could relate.”
Stat talks to the director of Nevada’s insurance exchange, where 14 of 17 counties had no insurers offering coverage under the Affordable Care Act, about lessons learned and the future of the marketplace. Meanwhile, KHN offers a look at the more out-of-the-box ideas on how to stabilize the industry.
A massive study look at how adults all over the world eat comes down on the side of fat, while carbohydrates get booted to the curb. In other public health news: more on the crackdown on stem cell clinics, dementia, good cholesterol, plastic surgery and more.
"Our current drug epidemic is indeed the deadliest in American history. We've seen nothing like it," said Attorney General Jeff Sessions on Tuesday. Meanwhile, officials explain why the crisis hasn't officially been declared a national emergency yet.
Even before the storm, changes in the health care landscape and other challenges have led Houston hospitals to cut thousands of jobs this year and record millions of dollars in losses. Meanwhile, media outlets give updates on how the flooding is affecting the facilities.
Limited drug access, power outages and floodwater injuries are challenges the residents of Houston will have to face right away. But the storm also brings long-term problems, such as mosquitoes, mold and damage to mental health. Meanwhile, experts say that the calls for tetanus shots amid the flooding are buying into an old wives' tale.
Today's early morning highlights from the major news organizations.
© 2026 KFF